Please login to the form below

Not currently logged in
Email:
Password:

Boehringer's Wolfram Carius to step down

He will be replaced by Wolfgang Baiker on the board of managing directors

Boehringer Ingelheim Wolfram CariusBoehringer Ingelheim's Professor Wolfram Carius (pictured right) is to step down after 26 years with the German pharma company.

He will leave Boehringer on June 30 as managing director responsible for biopharmaceuticals and production, after a career that included spells in Japan and Brazil.

“We are sad to see his departure and wish him all the best on his professional and personal way ahead,” said Professor Andreas Barner, chair of Boehringer's board of managing directors.

Prof Carius will be replaced by Dr Wolfgang Baiker, who has been with Boehringer since 1989 and is currently corporate senior VP for development.

His previous roles at the company include positions in the corporate board division Research, Development and Medicine in the US and Germany.

In a statement, the company said: “The shareholders and the board of managing directors believe that with this set up in the board of managing directors, it will continue to be well-equipped for the diverse challenges that face Boehringer Ingelheim and the research-driven pharmaceutical industry worldwide.”

21st May 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics